Buerger disease, also known as thromboangiitis obliterans, is a rare inflammatory disorder of the blood vessels. It is most commonly seen among young men who smoke, but it can also affect women and non-smokers. The cause of Buerger disease is unknown, but it is thought to be an autoimmune disorder. This means that the body's immune system attacks its own blood vessels, causing them to become inflamed and blocked. The disease typically affects the arteries and veins in the hands and feet, leading to pain, swelling, and ulceration. Early detection and treatment are essential for preventing further damage and improving quality of life.
Buerger disease is an inflammatory disorder of the blood vessels that primarily affects the arteries and veins in the hands and feet. It is an autoimmune disorder, meaning that the body's immune system mistakes its own blood vessels as foreign and attacks them. This leads to inflammation and narrowing of the blood vessels, which can cause pain, swelling, and ulceration of the affected areas. Buerger disease is most common in young men between the ages of 20 and 40 who smoke, but it can also affect women and non-smokers.
The exact cause of Buerger disease is unknown, but it is believed to be related to smoking. Smoking increases the risk of developing Buerger disease, and most people with the condition are current or former smokers. Other risk factors include family history, certain autoimmune disorders, and exposure to certain toxins.
The most common symptom of Buerger disease is pain in the hands and feet. This pain is usually worse at night and can be accompanied by swelling, numbness, tingling, and discoloration of the affected area. In advanced cases, ulceration and gangrene may occur.
Buerger disease can be difficult to diagnose because the symptoms are similar to other conditions. To diagnose Buerger disease, a doctor will typically take a medical history and perform a physical exam. The doctor may also order imaging tests such as X-rays, CT scans, and MRIs to look for signs of inflammation and narrowing of the blood vessels. Blood tests may also be done to look for signs of infection or autoimmune disorders.
The primary treatment for Buerger disease is to stop smoking. This is essential for slowing the progression of the disease and reducing the risk of complications. Other treatments include medications to reduce inflammation, relieve pain, and prevent blood clots. In severe cases, surgery may be needed to remove damaged blood vessels or to bypass them with healthy vessels.
The best way to prevent Buerger disease is to quit smoking. If you are a smoker, it is important to quit as soon as possible to reduce your risk of developing the disease. If you are a non-smoker, it is important to avoid secondhand smoke and other toxins that may increase your risk of developing the disease.
Buerger disease is a rare inflammatory disorder of the blood vessels that can cause pain, swelling, and ulceration of the hands and feet. The cause of the disease is unknown, but it is thought to be an autoimmune disorder. Early detection and treatment are essential for preventing further damage and improving quality of life. The best way to prevent the disease is to quit smoking, and if you are a smoker, it is important to quit as soon as possible.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation